Ashkan Emadi

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 21

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Pharmaceuticals (Basel, Switzerland)

Cancer chemotherapy and pharmacology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

L Susan Wieland, Sydney Shade, Ilana Moffet, Amir Ansari, Ashkan Emadi, Cheryl L Holt, Emily F Gorman, Christopher R D'Adamo
Effects of Antioxidant Dietary Supplement Use upon Response to Cancer Treatment: A Scoping Review of Available Evidence. Nutrition and cancer (2024)
Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Jessica K Altman, Tsila Zuckerman, Jamie Koprivnikar, James McCloskey, Vamsi Kota, Michael Keng, Olga Frankfurt, Yasmin Abaza, Dale Bixby, Ashkan Emadi, Micah Burch, Bhavana Bhatnagar, Selina M Luger, Mary-Elizabeth M Percival, Ofir Wolach, Michael Craig, Chezi Ganzel, Gail J Roboz, Itai Levi, Anna Gourevitch, Liat Flaishon, Shoshi Tessler, Chen Blomberg, Stela Gengrinovitch, Ruth Ben Yakar, Jacob M Rowe
Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study. Blood advances (2023)
Elizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, Kathryn A F Kline, Danielle Sewell, Jennie Y Law, Seung Tae Lee, Sandrine Niyongere, Vu H Duong, Maria R Baer, Ashkan Emadi
Impact of FLT3 -ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study. Biology 11 (6) (2022)
Casey L O'Connell, Maria R Baer, Andreas Due Ørskov, Sunil Kumar Saini, Vu H Duong, Patricia Kropf, Jakob Werner Hansen, Denice Tsao-Wei, Hyo Sik Jang, Ashkan Emadi, Staffan Holmberg-Thyden, Jack Bernard Cowland, Brett T Brinker, Kristin Horwood, Ryan S Burgos, Galen Hostetter, Benjamin A Youngblood, Sine Reker Hadrup, Jean-Pierre J Issa, Peter A Jones, Stephen B Baylin, Imran Siddiqi, Kirsten Grønbaek
Safety, outcomes and T cell characteristics in patients with relapsed or refractory MDS or CMML treated with atezolizumab in combination with guadecitabine. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Kanwal Mahmood, Ashkan Emadi
1-C Metabolism-Serine, Glycine, Folates-In Acute Myeloid Leukemia. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, Kyle Zacholski, Vu H Duong, Firas El Chaer, Noa G Holtzman, Ivana Gojo, Jonathan A Webster, Kelly J Norsworthy, Bruce Douglas Smith, Amy E DeZern, Mark J Levis, Maria R Baer, Farin Kamangar, Gabriel Ghiaur, Ashkan Emadi
FLT3-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification. Biology 10 (3) (2021)
Sarah M Kashanian, Noa G Holtzman, Ciera L Patzke, Jonathan Cornu, Alison P Duffy, Madhurima Koka, Sandrine Niyongere, Vu H Duong, Maria R Baer, Jummai Apata, Farin Kamangar, Ashkan Emadi
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens. Cancer chemotherapy and pharmacology 87 (6) (2021)
Ashkan Emadi, Bandish Kapadia, Dominique Bollino, Binny Bhandary, Maria R Baer, Sandrine Niyongere, Erin T Strovel, Hannah Kaizer, Elizabeth Chang, Eun Yong Choi, Xinrong Ma, Kayla M Tighe, Brandon Carter-Cooper, Blake S Moses, Curt I Civin, Anup A Mahurkar, Amol Carl Shetty, Ronald B Gartenhaus, Farin Kamangar, Rena G Lapidus
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia. Leukemia 35 (7) (2020)
Ciera L Patzke, Alison P Duffy, Vu H Duong, Firas El Chaer, James A Trovato, Maria R Baer, Søren M Bentzen, Ashkan Emadi
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia. Journal of clinical medicine 9 (2) (2020)
Sandrine Niyongere, Gabriela Sanchez-Petitto, Jack Masur, Maria R Baer, Vu H Duong, Ashkan Emadi
Frontline Blinatumomab in Older Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 13 (6) (2020)
Ashkan Emadi, Joel V Chua, Rohit Talwani, Søren M Bentzen, John Baddley
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials 21 (1) (2020)
Sunil Adige, Rena G Lapidus, Brandon A Carter-Cooper, Alison Duffy, Ciera Patzke, Jennie Y Law, Maria R Baer, Nicholas P Ambulos, Ying Zou, Søren M Bentzen, Ashkan Emadi
Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation. Cancer chemotherapy and pharmacology 83 (6) (2019)
Michelle H Lee, Rena G Lapidus, Dana Ferraris, Ashkan Emadi
Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics. Molecules (Basel, Switzerland) 24 (17) (2019)
Rupa Narayan, Traci M Blonquist, Ashkan Emadi, Robert P Hasserjian, Meghan Burke, Christopher Lescinskas, Donna S Neuberg, Andrew M Brunner, Gabriela Hobbs, Hanno Hock, Steven L McAfee, Yi-Bin Chen, Eyal Attar, Timothy A Graubert, Christina Bertoli, Jenna A Moran, Meghan K Bergeron, Julia E Foster, Aura Y Ramos, Tina T Som, Megan K Vartanian, Jennifer L Story, Kristin McGregor, Molly Macrae, Tanya Behnan, Margaret C Wey, Jessica Rae, Frederic I Preffer, Patricia Lesho, Vu H Duong, Mason L Mann, Karen K Ballen, Christine Connolly, Philip C Amrein, Amir T Fathi
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia. Cancer 126 (6) (2019)
Sameer Sawhney, Noa G Holtzman, Derik L Davis, Hannah Kaizer, Victoria Giffi, Ashkan Emadi, Madhurima Koka
Promyelocytic sarcoma of the right humerus: an unusual clinical presentation with unique diagnostic and treatment considerations. Clinical case reports 5 (11) (2017)
Ashkan Emadi, Jennie Y Law, Erin T Strovel, Rena G Lapidus, Linda J B Jeng, Myounghee Lee, Miriam G Blitzer, Brandon A Carter-Cooper, Danielle Sewell, Isabella Van Der Merwe, Sunita Philip, Mohammad Imran, Stephen L Yu, Hongxia Li, Philip C Amrein, Vu H Duong, Edward A Sausville, Maria R Baer, Amir T Fathi, Zeba Singh, Søren M Bentzen
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia. Cancer chemotherapy and pharmacology 81 (1) (2017)
Ashkan Emadi
Exploiting AML vulnerability: glutamine dependency. Blood 126 (11) (2015)